Serum miR-22 may be a biomarker for papillary thyroid cancer.
Serum miR-22 may be a biomarker for papillary thyroid cancer. — المؤلف: Wang, Deping — Oncology letters Mar 2019
- المؤلف
- Wang, Deping
- النشر
- Oncology letters Mar 2019
- الوصف
- 3355-3361 p.
Serum miR-22 may be a biomarker for papillary thyroid cancer. — المؤلف: Wang, Deping — Oncology letters Mar 2019